Title: 
Official Title: To direct the Secretary of Veterans Affairs to establish a pilot program to furnish hyperbaric oxygen therapy to a veteran who has a traumatic brain injury or post-traumatic stress disorder.
Number of Sections: 2
Source: versions - Introduced in House
Media Type: text/xml

================================================================================

Section 1:
1.Short titleThis Act may be cited as the Veterans National Traumatic Brain Injury Treatment Act.

Section 2:
2.Pilot program to furnish hyperbaric oxygen therapy to a veteran with traumatic brain injury or post-traumatic stress disorder(a)EstablishmentThe Secretary of Veterans Affairs shall implement a pilot program to furnish HBOT to a veteran who has a traumatic brain injury or post-traumatic stress disorder through a health care provider described in section 1703(c)(5) of title 38, United States Code.(b)LocationsThe Secretary shall select three Veterans Integrated Service Networks in which to operate the pilot program.(c)Funding(1)There is in the general fund of the Treasury a fund to be known as the VA HBOT Fund (in this Act referred to as the Fund).(2)The sole source of monies for the Fund shall be donations received by the Secretary for express purposes of the Fund.(3)Amounts in the Fund shall be available to the Secretary without fiscal year limitation to pay for HBOT under subsection (a).(4)The Fund shall terminate on the termination date under subsection (d).(d)TerminationThe pilot program shall terminate on the day that is five years after the date of the enactment of this Act.(e)HBOT definedIn this Act, the term HBOT means hyperbaric oxygen therapy with a medical device—(1)approved by the Food and Drug Administration; or(2)issued an investigational device exemption by the Food and Drug Administration.


================================================================================

Raw Text:
119 HR 1336 IH: Veterans National Traumatic Brain Injury Treatment Act
U.S. House of Representatives
2025-02-13
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.



I119th CONGRESS1st SessionH. R. 1336IN THE HOUSE OF REPRESENTATIVESFebruary 13, 2025Mr. Murphy (for himself, Mr. Davis of North Carolina, Mrs. Kiggans of Virginia, Ms. Strickland, Mr. Wittman, Ms. Malliotakis, Ms. Ross, Mr. Van Orden, and Mrs. Biggs of South Carolina) introduced the following bill; which was referred to the Committee on Veterans' AffairsA BILLTo direct the Secretary of Veterans Affairs to establish a pilot program to furnish hyperbaric oxygen therapy to a veteran who has a traumatic brain injury or post-traumatic stress disorder.1.Short titleThis Act may be cited as the Veterans National Traumatic Brain Injury Treatment Act.2.Pilot program to furnish hyperbaric oxygen therapy to a veteran with traumatic brain injury or post-traumatic stress disorder(a)EstablishmentThe Secretary of Veterans Affairs shall implement a pilot program to furnish HBOT to a veteran who has a traumatic brain injury or post-traumatic stress disorder through a health care provider described in section 1703(c)(5) of title 38, United States Code.(b)LocationsThe Secretary shall select three Veterans Integrated Service Networks in which to operate the pilot program.(c)Funding(1)There is in the general fund of the Treasury a fund to be known as the VA HBOT Fund (in this Act referred to as the Fund).(2)The sole source of monies for the Fund shall be donations received by the Secretary for express purposes of the Fund.(3)Amounts in the Fund shall be available to the Secretary without fiscal year limitation to pay for HBOT under subsection (a).(4)The Fund shall terminate on the termination date under subsection (d).(d)TerminationThe pilot program shall terminate on the day that is five years after the date of the enactment of this Act.(e)HBOT definedIn this Act, the term HBOT means hyperbaric oxygen therapy with a medical device—(1)approved by the Food and Drug Administration; or(2)issued an investigational device exemption by the Food and Drug Administration.